Microfluidics Research Report 2026-2035: A $20.73 Billion Market By 2030 With Thermo Fisher Scientific, Perkinelmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, And Fluidigm Leading
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value (USD) in 2026 | $11.89 Billion |
| Forecasted Market Value (USD) by 2030 | $20.73 Billion |
| Compound Annual Growth Rate | 14.9% |
| Regions Covered | Global |
Key Technologies & Future Trends
- Biotechnology, Genomics & Precision Medicine Artificial Intelligence & Autonomous Intelligence Industry 4.0 & Intelligent Manufacturing Digitalization, Cloud, Big Data & Cybersecurity Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems Integration of Microfluidics in Drug Delivery Systems Adoption of Microfluidics in Clinical Diagnostics Expansion of Pharmaceutical and Life Science Research Applications Development of Industrial and Environmental Microfluidics Solutions Advancement in High-Precision Fluid Manipulation Technologies
Companies Featured
- Agilent Technologies Bio-Rad Laboratories Fluidigm Corporation Dolomite Microfluidics PerkinElmer, Inc. Sphere Fluidics Limited Micronit Micro Technologies B.V. Fluigent Elveflow Cellix Ltd. Microliquid S.L. Biosurfit S.A. FlowJEM uFluidix QuantWave Technologies Inc. Harvard Bioscience, Inc. Abaxis, Inc. OPKO Health, Inc. Abbott Stamm
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
-
Microfluidics Market
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment